AGM/EGM4 Sept 2026, 01:27 pm
Biogen Pharmachem to hold 31st AGM on Sep 29, 2026 via VC/OAVM
AI Summary
Biogen Pharmachem Industries Ltd has announced its 31st Annual General Meeting (AGM) will be held on Tuesday, September 29, 2026, at 04:00 P.M. The meeting will be conducted entirely through Video Conferencing (VC) / Other Audio Visual Means (OAVM), in compliance with recent regulatory circulars. Key agenda items include the adoption of audited financial statements for the fiscal year ended March 31, 2026, the reappointment of a director retiring by rotation, and the reappointment of M/s. Goenka Mehta & Associates as statutory auditors for a term of five years. The company has also noted that proxy appointments will not be available for this virtual meeting.
Key Highlights
- AGM scheduled for September 29, 2026, via VC/OAVM.
- Audited financial statements for FY26 to be adopted.
- Director Mr. Kelash Bunkar up for re-appointment.
- Statutory auditors Goenka Mehta & Associates to be reappointed.
- Auditors' term extended to AGM in 2031.
Price Impact
More from BIOGEN